Concert Pharmaceuticals Inc. buy klostergang
Start price
07.04.17
/
50%
€14.68
Target price
09.10.17
€22.55
Performance (%)
-5.90%
End price
09.10.17
€13.81
Summary
This prediction ended on 09.10.17 with a price of €13.81. With a performance of -5.90%, the BUY prediction by klostergang finished with a loss. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by klostergang for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert has several big name partners and several "shots on goal" in its pipeline
![]()
Stifel Nicolaus and Aegis Capital reiterated Buy ratings on this small
cap "Tier 4" biotech stock yesterday (05.04.2017) with price targets of $31 and $25
(Laufzeit überschritten)


